Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details) - Schedule of stock option activity

v3.22.4
Stockholders' Equity (Details) - Schedule of stock option activity
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Weighted Average Exercise Price
Stock Options, Total Outstanding (in Shares) | shares 317,857
Stock Options, Number Exercisable (in Shares) | shares 194,853
6.00 To 60.60 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum $ 6
Stock Options, Grant Price, Maximum 60.6
Stock Options, Weighted Average Exercise Price $ 34.32
Stock Options, Total Outstanding (in Shares) | shares 268,357
Stock Options, Number Exercisable (in Shares) | shares 147,218
Stock Options, Weighted Average Remaining Contractual Term 7 years 2 months 12 days
63.00 To 138.00 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum $ 63
Stock Options, Grant Price, Maximum 138
Stock Options, Weighted Average Exercise Price $ 78.22
Stock Options, Total Outstanding (in Shares) | shares 38,066
Stock Options, Number Exercisable (in Shares) | shares 36,201
Stock Options, Weighted Average Remaining Contractual Term 5 years 3 days
159.00 To 265.80 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum $ 159
Stock Options, Grant Price, Maximum 265.8
Stock Options, Weighted Average Exercise Price $ 172.14
Stock Options, Total Outstanding (in Shares) | shares 11,434
Stock Options, Number Exercisable (in Shares) | shares 11,434
Stock Options, Weighted Average Remaining Contractual Term 5 years 3 months 25 days